AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Evaluation of Treatments for Sore Throat Associated With Acute Pharyngitis and/or Viral Tonsillitis

RecruitingNAAges 18 Years - 70 YearsAllUniversity Hospital, Clermont-Ferrand
💬

In plain words

What the trial is, and whether it could suit you

The objective of this study is to conduct post-marketing clinical follow-up of four products: HMG, PHN, PHR, and TUR. This follow-up will consist of collecting clinical data in real-life conditions to confirm the tolerance, safety, and efficacy of medical devices used in the treatment of sore throats related to acute pharyngitis and/or viral-origin tonsillitis, while also assessing the benefit/risk ratio of the products.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Pharyngitis or tonsillitis or acute nasopharyngitis or viral-origin sore throat with odynophagia that began less than 72 hours before the inclusion visit according to the investigator's judgment * Bacterial rhinopharyngitis with negative TROD test * Effective contraception for female patients of childbearing age * Cooperation and sufficient understanding to comply with the requirements of the trial * Acceptance of registration in the SI-RIPH database * Having received informed information and agreeing to give written consent * Affiliated with the French Social Security scheme. Exclusion Criteria: * Hypersensitivity/previous allergy to any of the product components, * Pharyngitis or tonsillitis or acute rhinopharyngitis complicated (phlegmon, acute otitis media, pneumonia…) or severely intolerable cough, * Positive antigen test for influenza A/B or COVID-19 and infection requiring etiological treatment according to the recommendations, * Other ongoing treatments for acute pharyngitis or tonsillitis (local treatment, antibiotics, corticosteroids, antiretroviral…), * Comorbidities or health conditions deemed incompatible with the trial by the investigator, * Recent otorhinolaryngology surgery (\<6 months), * Pulmonary pathology (Chronic Obstructive Pulmonary Disease, asthma…), * Immunosuppression (according to patient's report), * Pregnant or breastfeeding women, * Currently participating in another clinical trial, or in the exclusion period, or having received total compensation of more than €6,000 in the 12 months prior to the start of the trial, * Benefiting from legal protection measures (guardianship, trusteeship, deprivation of liberty, judicial protection).
💊

What it tests

  • HMG
  • PHN
  • PHR
  • TUR
📍

Where

1 site
Chu Clermont Ferrand
Clermont-Ferrand, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy